Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,225 INR | -0.09% |
|
-1.19% | +43.62% |
06-12 | India Equities Close Higher Ahead of US Inflation Data | MT |
06-12 | Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.62% | 4.14B | |
+20.13% | 43.67B | |
+26.21% | 22.79B | |
+20.25% | 15.45B | |
+17.83% | 14.29B | |
+53.18% | 12.83B | |
-0.05% | 6.79B | |
-11.88% | 6.52B | |
+12.62% | 5.59B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Widens Consolidated Net Loss in Fiscal Q4